ROSEANN BARRERA: Open Payments
NPI 1851953285 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 38 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| BeOne Medicines USA, Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $41 |
| Caris MPI, Inc. | 1 | $33 |
| Aveo Pharmaceuticals, Inc. | 1 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $29 |
Products named: KEYTRUDA, ERLEADA, Nubeqa, MI CANCER SEEK, IMFINZI, FOTIVDA, DANZITEN, Amtagvi.
Industry payments across NC — which companies pay providers there.
